Rigel Pharmaceuticals (RIGL) Net Margin (2010 - 2026)
Rigel Pharmaceuticals (RIGL) posted quarterly Net Margin of 14.71% for Q1 2026, down 675.0% year-over-year from 2.56% in Q1 2025, and down 96.17% quarter-over-quarter from 384.04% in Q4 2025.
Rigel Pharmaceuticals (RIGL) Net Margin (2010 - 2026) Analysis & Trends
Rigel Pharmaceuticals' Net Margin history runs 16 years deep, the most recent figure standing at 14.71% for Q1 2026.
- In Q1 2026, Net Margin fell 675.0% year-over-year to 14.71%; the TTM figure through Mar 2026 stood at 121.51% (up 10320.0% YoY), while the FY2025 annual figure was 124.72%, up 11497.0% from the prior year.
- Net Margin for Q1 2026 stood at 14.71%, down from 384.04% in the prior quarter.
- The five-year high for Net Margin was 384.04% in Q4 2025, with the low at 164.0% in Q1 2022.
- The 5-year median for Net Margin is 0.17% (2023), against an average of 8.67%.
- The sharpest annual moves came in 2022 and 2025: Net Margin slumped 21275 bps in 2022, then jumped 35914 bps in 2025.
- Rigel Pharmaceuticals' Net Margin stood at 2.73% in 2022, then plunged by 106 bps to 0.17% in 2023, then surged by 14710 bps to 24.9% in 2024, then surged by 1442 bps to 384.04% in 2025, then tumbled by 96 bps to 14.71% in 2026.
- Business Quant data shows RIGL's Net Margin at 14.71% in Q1 2026, 384.04% in Q4 2025, and 40.17% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 30.33% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.90% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 30.98% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 12.09% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 12.74% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -3.12% |
| 10 | Rigel Pharmaceuticals | 795.39 Mn | 700.06 Mn | 70.18 Mn | 21.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.97% |
| Mar 31, 2026 | 14.71% |
| Dec 31, 2025 | 384.04% |
| Sep 30, 2025 | 40.17% |
| Jun 30, 2025 | 58.63% |
| Mar 31, 2025 | 21.46% |
| Dec 31, 2024 | 24.90% |
| Sep 30, 2024 | 22.46% |
| Jun 30, 2024 | -2.80% |
| Mar 31, 2024 | -27.92% |
| Dec 31, 2023 | -0.17% |
| Sep 30, 2023 | -20.23% |
| Jun 30, 2023 | -24.55% |
| Mar 31, 2023 | -51.92% |
| Dec 31, 2022 | 2.73% |
| Sep 30, 2022 | -84.95% |
| Jun 30, 2022 | -45.25% |
| Mar 31, 2022 | -164.00% |
| Dec 31, 2021 | -110.76% |
| Sep 30, 2021 | -97.26% |